The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
hepatitis b vaccine (recombinant) adjuvanted
3 marketed package NDCs · 3 active manufacturers
Most dispensed: HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN 20 ug/.5mL · Injection, Solution · #5 syringes/carton / .5 ml in 1 syringe
Same drug class
Other molecules FDA puts in Inactivated Hepatitis B Virus Vaccine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Hepatitis b vaccine (recombinant) adjuvanted in shortage right now?
- No. FDA does not currently list Hepatitis b vaccine (recombinant) adjuvanted in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Hepatitis b vaccine (recombinant) adjuvanted?
- 3 companies have marketed Hepatitis b vaccine (recombinant) adjuvanted in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.